Remove 2030 Remove Packaging Remove Vaccines
article thumbnail

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock.

article thumbnail

3 of the year’s most notable FDA nods

PharmaVoice

Now, the WHO’s aggressive goal to “ end HIV/AIDS ” by 2030 could be hampered by dramatic reductions in U.S. A long-time leader in vaccines, the U.K. million Americans are infected with HIV, but the disease disproportionately impacts people in sub-Saharan Africa. While Enhertu pulled in about $3.8

FDA 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed.

article thumbnail

Chugai and Gero link on antibody drugs for age-related conditions

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Chugai president and CEO Dr Osamu Okuda stated: “We believe that open innovation with external partners, including leading global players, is extremely important for achieving global first-class drug discovery outlined in our growth strategy toward 2030, TOP I 2030. “By

article thumbnail

UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears

Pharmaceutical Technology

The UK has confirmed its support for global vaccination by pledging £1.25bn to global vaccine group Gavi while the US will halt funding to the international organisation. The group had set a fundraising target of $11.9bn for its 2026-2030 budget. Credit: speedshutter Photography via Shutterstock.

article thumbnail

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

PharmTech

Shifts in sterile manufacturing include isolator tech adoption and packaging tailored to personalized medicine, at-home use, and chronic disease treatments. Pharmapack Europe 2025: Packaging Trends. At that time, Mahler said revisions to regulatory guidance were having an impact on fill/finish facilities. PharmTech.com , Jan.

Dosage 45
article thumbnail

FDA approves label expansion of AbbVie hepatitis C therapy

Pharmaceutical Technology

“The label expansion for Mavyret, coupled with the implementation of ‘test and treat’ models of care, serves as a tool to support the public health community in treating more patients and bringing us closer to achieving the global 2030 elimination goal.” Give your business an edge with our leading industry insights.